Business Strategy Kemira, IFF Joint Venture Relocates Biobased Materials Manufacturing Site

Source: Press release Kemira 1 min Reading Time

Related Vendors

Kemira and IFF have announced that their planned biobased materials manufacturing site has now been relocated from Kotka to Hanko in Finland. The new site specializes in industrial enzymes for the home and personal care, and food and beverage sectors.

Project engineering and permitting activities will now transition to Hanko in Finland. (Source:  Unsplash)
Project engineering and permitting activities will now transition to Hanko in Finland.
(Source: Unsplash)

Helsinki/Finland – Kemira and IFF have recently announced an update to the previously communicated plans regarding the future location of their Alpha Bio joint venture manufacturing plant for biobased materials at a commercial scale. Project engineering and permitting activities will now transition to Hanko. Following a detailed evaluation, the location of the previously planned manufacturing plant will be changed from IFF Kotka site to another IFF manufacturing plant in Hanko, both in Southern Finland. The IFF Hanko site specializes in industrial enzymes for the home and personal care, and food and beverage sectors.

The joint venture, originally announced in 2025, represents an estimated total investment of approximately 130 million euros. Both companies will continue to hold a 50 % stake, and commercial production is now expected to begin in 2029. The original estimate for the commercial production start was late 2027.

The joint venture will continue to leverage IFF’s proprietary Designed Enzymatic Biomaterial (DEB) technology platform, which uses plant‑based sugars to produce high‑performance biobased materials for a wide range of industrial applications. Kemira retains global exclusivity for commercialization of DEB solutions in the Paper, Board, and Water Treatment markets.

(ID:50875930)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent